Acer Therapeutics INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersBoston, MA
US patents4
SAM.gov UEIC6EKP8VELDC1
CAGE code76BR6
Incorporated inDE
LEI549300BRA7GF5PCH1L04
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
4 US patents granted 2021–2024, 4 of them in the five years to SEP 2025.
Pharmaceuticals 4
- Solid forms of emetineUS 11,884,663 · granted JAN 30, 2024
- Palatable compositions including sodium phenylbutyrate and uses thereofUS 11,433,041 · granted SEP 6, 2022
- Methods of treating urea cycle disorders and maple syrup urine diseaseUS 11,202,767 · granted DEC 21, 2021
- Palatable compositions including sodium phenylbutyrate and uses thereofUS 11,154,521 · granted OCT 26, 2021
Granted to Acer Therapeutics, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Acer Therapeutics INC. | Boston | MA | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.